Q32 Bio Inc.
QTTB
$1.55
-$0.135-8.01%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 47.58% | -25.40% | -192.37% | 115.05% | -179.39% |
| Total Depreciation and Amortization | -3.23% | -0.81% | -2.42% | -3.15% | -3.13% |
| Total Amortization of Deferred Charges | 63.33% | 614.29% | 164.00% | 16.00% | 20.00% |
| Total Other Non-Cash Items | -13.06% | -82.38% | 255.36% | -3,311.02% | -0.96% |
| Change in Net Operating Assets | -93.21% | -114.19% | -39.27% | 90.83% | -16.53% |
| Cash from Operations | -6.65% | -222.77% | -95.43% | -16.45% | -212.55% |
| Capital Expenditure | -- | -5,700.00% | -1,600.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 994,300.00% | 988,700.00% | 2,040.00% | -100.00% |
| Total Debt Issued | -- | -100.00% | -- | -- | -100.00% |
| Total Debt Repaid | -- | 100.00% | -- | -- | -- |
| Issuance of Common Stock | 317.11% | -- | 2,433.33% | 279,900.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 317.11% | 232.33% | -36,913.33% | 662,206.67% | -99.54% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.46% | -152.98% | -57.24% | 779.90% | -140.60% |